ZL-1102 / ZAI Lab 
Welcome,         Profile    Billing    Logout  
  Diseases    Trials    Trials    News 
1 Trials

   

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
ZL-1102 / ZAI Lab
NCT06380907: A Phase 2 Study of ZL-1102 in Patients With Chronic Plaque Psoriasis

Recruiting
2
250
RoW
ZL-1102 1% w/w gel BID for 16 weeks, ZL-1102 3% w/w gel BID for 16 weeks, ZL-1102 3% w/w gel QD for 16 weeks, Placebo ZL-1102 0% w/w gel BID for 16 weeks, Placebo ZL-1102 0% w/w gel QD for 16 weeks
Zai Lab (Hong Kong), Ltd., Zai Lab (US) LLC
Plaque Psoriasis
02/26
03/26

Download Options